Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dual versus triple antithrombotic therapy after percutaneous coronary intervention: the prospective multicentre WOEST 2 Study.
Bor WL, de Veer AJW, Olie RH, Rikken SAOF, Chan Pin Yin DRPP, Herrman JPR, Vrolix M, Meuwissen M, Vandendriessche T, van Mieghem C, Magro M, Bennaghmouch N, Hermanides R, Adriaenssens T, Dewilde WJM, Ten Berg JM. Bor WL, et al. EuroIntervention. 2022 Jul 22;18(4):e303-e313. doi: 10.4244/EIJ-D-21-00703. EuroIntervention. 2022. PMID: 35370126 Free PMC article.
Rationale and Design of the Future Optimal Research and Care Evaluation in Patients with Acute Coronary Syndrome (FORCE-ACS) Registry: Towards "Personalized Medicine" in Daily Clinical Practice.
Chan Pin Yin DRPP, Vos GA, van der Sangen NMR, Walhout R, Tjon Joe Gin RM, Nicastia DM, Langerveld J, Claassens DMF, Gimbel ME, Azzahhafi J, Bor WL, Oirbans T, Dekker J, Vlachojannis GJ, van Bommel RJ, Appelman Y, Henriques JPS, Kikkert WJ, Ten Berg JM. Chan Pin Yin DRPP, et al. Among authors: bor wl. J Clin Med. 2020 Sep 30;9(10):E3173. doi: 10.3390/jcm9103173. J Clin Med. 2020. PMID: 33007932 Free PMC article.
Pharmacokinetics, pharmacodynamics, and tolerability of subcutaneous administration of a novel glycoprotein IIb/IIIa inhibitor, RUC-4, in patients with ST-segment elevation myocardial infarction.
Bor WL, Zheng KL, Tavenier AH, Gibson CM, Granger CB, Bentur O, Lobatto R, Postma S, Coller BS, van 't Hof AWJ, Ten Berg JM. Bor WL, et al. EuroIntervention. 2021 Aug 6;17(5):e401-e410. doi: 10.4244/EIJ-D-21-00287. EuroIntervention. 2021. PMID: 34031019 Free PMC article. Clinical Trial.
Feasibility and safety of cangrelor in patients with suboptimal P2Y12 inhibition undergoing percutaneous coronary intervention: rationale of the Dutch Cangrelor Registry.
Selvarajah A, Tavenier AH, Bor WL, Houben V, Rasoul S, Kaplan E, Teeuwen K, Hofma SH, Lipsic E, Amoroso G, van Leeuwen MAH, Berg JMT, van 't Hof AWJ, Hermanides RS. Selvarajah A, et al. Among authors: bor wl. BMC Cardiovasc Disord. 2021 Jun 12;21(1):292. doi: 10.1186/s12872-021-02093-4. BMC Cardiovasc Disord. 2021. PMID: 34118880 Free PMC article.
A novel risk score to identify the need for triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention: a post hoc analysis of the RE-DUAL PCI trial.
Zwart B, Bor WL, de Veer AJWM, Mahmoodi BK, Kelder JC, Lip GYH, Bhatt DL, Cannon CP, Ten Berg JM. Zwart B, et al. Among authors: bor wl. EuroIntervention. 2022 Jul 22;18(4):e292-e302. doi: 10.4244/EIJ-D-21-00165. EuroIntervention. 2022. PMID: 35105533 Free PMC article.
Diagnostic Performance of CCTA and CT-FFR for the Detection of CAD in TAVR Work-Up.
Peper J, Becker LM, van den Berg H, Bor WL, Brouwer J, Nijenhuis VJ, van Ginkel DJ, Rensing BJMW, Ten Berg JM, Timmers L, Leiner T, Swaans MJ. Peper J, et al. Among authors: bor wl. JACC Cardiovasc Interv. 2022 Jun 13;15(11):1140-1149. doi: 10.1016/j.jcin.2022.03.025. Epub 2022 May 11. JACC Cardiovasc Interv. 2022. PMID: 35680194 Free article.
Effects of CYP3A4*22 and CYP3A5 on clinical outcome in patients treated with ticagrelor for ST-segment elevation myocardial infarction: POPular Genetics sub-study.
Azzahhafi J, Bergmeijer TO, van den Broek WWA, Chan Pin Yin DRPP, Rayhi S, Peper J, Bor WL, Claassens DMF, van Schaik RHN, Ten Berg JM. Azzahhafi J, et al. Among authors: bor wl. Front Pharmacol. 2022 Dec 5;13:1032995. doi: 10.3389/fphar.2022.1032995. eCollection 2022. Front Pharmacol. 2022. PMID: 36545312 Free PMC article.
Periprocedural continuation versus interruption of oral anticoagulant drugs during transcatheter aortic valve implantation: rationale and design of the POPular PAUSE TAVI trial.
van Ginkel DJ, Bor WL, Dubois CLF, Aarts HM, Rooijakkers MJP, van Bergeijk KH, Rosseel L, Veenstra L, De Backer O, Van Mieghem NM, van der Kley F, Wilgenhof A, Leonora R, Halim J, Schotborgh CE, Barbato E, Van Der Heyden JAS, Frambach P, Ferdinande B, Mylotte D, Fabris E, Rensing BJWM, Timmers L, Swaans MJ, Brouwer J, Nijenhuis VJ, Peper J, Vriesendorp PA, de Laat B, Ninivaggi M, Stragier H, Voskuil M, IJsselmuiden AJJ, Hermanides RS, Agostoni P, van 't Hof AWJ, Wykrzykowska JJ, van Royen N, Delewi R, Ten Berg JM. van Ginkel DJ, et al. Among authors: bor wl. EuroIntervention. 2023 Nov 17;19(9):766-771. doi: 10.4244/EIJ-D-23-00206. EuroIntervention. 2023. PMID: 37605804 Free article. Clinical Trial.
19 results